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Skeletal muscle–derived stem cells (MDSCs) are able to differentiate into cardiomyocytes (CMs). However, it
remains to be investigated whether differentiated CMs contract similar to native CMs. Here, we developed a
three-dimensional collagen gel bioreactor (3DGB) that induces a working CM phenotype from MDSCs, and the
contractile properties are directly measured as an engineered cardiac tissue. Neonate rat MDSCs were isolated
from hind-leg muscles via the preplate technique. Isolated MDSCs were approximately 60% positive to Sca-1
and negative to CD34, CD45, or c-kit antigens. We sorted Sca-1() MDSCs and constructed MDSC-3DGBs by
mixing MDSCs with acid soluble rat tail collagen type-I and matrix factors. MDSC-3DGB exhibited spontaneous
cyclic contraction by culture day 7. MDSC-3DGB expressed cardiac-specific genes and proteins. Histological
assessment revealed that cardiac-specific troponin-T and -I expressed in a typical striation pattern and connexin-
43 was expressed similar to the native fetal ventricular papillary muscle. b-Adrenergic stimulation increased
MDSC-3DGB spontaneous beat frequency. MDSC-3DGB generated contractile force and intracellular calcium
ion transients similar to engineered cardiac tissue from native cardiac cells. Results suggest that MDSC-3DGB
induces a working CM phenotype in MDSCs and is a useful 3D culture system to directly assess the contractile
properties of differentiated CMs in vitro.
Introduction
Limited cardiomyocyte (CM) proliferative capacity is amajor barrier to myocardial regeneration and the resto-
ration of contractile function of injured postnatal myocar-
dium. Various strategies to restore postnatal CM proliferation
and myocardial regeneration are under investigation, in-
cluding strategies for the repair and regeneration of damaged
myocardium using allogeneic and autologous cell and tissue
grafts.1 Studies suggest that fetal, finitely proliferating CMs
display the best cell survival, functional integration, and
sustained cardiac recovery, and thus could be an optimal cell
type for cardiac repair.2,3 However, the use of fetal heart cells
is contraindicated for clinical use. Stem cells provide an al-
ternative solution, and a range of cell types have been em-
ployed in cellular cardiomyoplasty strategies, including bone
marrow–derived stromal and stem cells, fibroblasts, skeletal
myoblasts, mesenchymal stem cells, embryonic stem cells,
and resident cardiac stem cells.4 However, despite some
promising results,5 the rate of CM differentiation from
transplanted stem cells remains insufficient to fully recover
the recipient myocardial function.2,4, 6–8 Therefore, a preferred
strategy for cellular cardiomyoplasty might be the delivery of
progenitor=stem cell–derived CMs, rather than undifferenti-
ated cells, into injured myocardial tissue.9
Skeletal muscle–derived stem cells (MDSCs) are a somatic
stem cell population obtained from skeletal muscle speci-
mens in animals and humans that can be readily expanded
in vitro and then transplanted as an autologous graft.8,10,11
MDSCs are multipotent and have been shown to differenti-
ate along skeletal and smooth muscle, bone, tendon, nerve,
endothelial, and hematopoietic lineages.10,12,13 Previous
studies, including our own work, have shown that MDSCs,
isolated using variations of a modified preplate technique,
can differentiate into CMs or cells with cardiac phenotypes
and can facilitate cardiac repair.8,14–20 However, none of the
previous studies investigated whether differentiated MDSC-
derived CMs generate contractile force similar to the native
CMs. In addition, undifferentiated MDSCs or MDSCs pre-
conditioned with chemical reagents were used to evaluate
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in vivo CM differentiation from MDSCs, not transplanted
MDSC-derived CMs in animal models of injured myocar-
dium.1,5 Our recent studies have also shown that the rate of
CM differentiation of transplanted MDSCs within acute
myocardial infarction model is not sufficient to replace in-
jured CMs, and improvement of recipient cardiac function by
MDSC transplantation is due to combined effects of myo-
genic differentiation of transplanted MDSC, angiogenesis,
stimulation of recipient CM proliferation, and reduction of
recipient CM apoptosis.8,20 Therefore, it remains unclear
whether differentiated CM phenotypic cells replace recipient
dead CMs and have contractile function that improves re-
cipient cardiac function.
The effects of various biomechanical stimuli on multi-
potent stem cells have been investigated to elucidate their
roles in CM induction and differentiation. Previous studies
have shown that cell–cell interactions and specific culture
conditions are often necessary prerequisites for efficient CM
differentiation.21–23 The culture of multipotent stem cells in
aggregate spheres has been shown to facilitate cell–cell cou-
pling, increase differentiation capacity, modify cellular me-
tabolism, modulate the response to therapeutic agents,23–25
and stimulate the synthesis and release of extracellular ma-
trix (ECM) constituents.26 Studies also suggest that three-
dimensional (3D) in vitro culture conditions may be optimal
for donor CM preparation,2,3,27 and that tissue-engineered
cardiac tissue constructs provide the requisite 3D environ-
ment for efficient cell survival, functional integration, and
sustained cardiac recovery.27,28
Thus, the objective of the present study was to develop a
culture method that induces CM differentiation from MDSCs
and facilitates myocardial tissue formation that enables us to
directly evaluate the contractile properties of MDSC-derived
CMs in vitro. We tested the hypothesis that the combined
MDSC-aggregate formation and 3D collagen gel bioreactor
can induce MDSCs to differentiate into cells with a CM
phenotype and that the differentiated CMs form a working
3D cardiac like tissue in vitro. We determined that MDSC-
aggregate formation followed by 3D collagen gel bioreactor
(3DGB) culture succeeded in generating cells with an im-
mature CM phenotype mimicking the native fetal myocar-
dium. Thus, our results suggest that MDSC-3DGB is a useful
3D culture system to directly assess the contractile properties
of differentiated CMs from MDSCs in vitro.
Materials and Methods
MDSC isolation
MDSCs were isolated from neonatal Lewis rat hind-leg
muscles using an established preplate technique.10–12,29–31
Briefly, five postnatal day-3 rat pups were euthanized with
5% isoflurane anesthesia followed by cervical truncation.
Gastrocnemius muscles were excised, minced in HBSS, and
enzymatically digested. Briefly, tissue slurry underwent se-
quential incubation of collagnease XI (0.2% collagenase XI),
dispase (2.4 U=mL), and 2 trypsin. Isolated cells then un-
derwent sequential preplating (24-h interval between each
preplate) until the sixth preplate phase31 in standard MDSC
growth medium containing high-glucose Dulbecco’s modi-
fied Eagle’s medium w=l-glutamine (Invitrogen, Carlsbad,
CA), 10% horse serum (Invitrogen), 10% fetal bovine serum
(FBS; Invitrogen), 0.5% chick embryo extract (US Biological,
Swampscott, MA), and 1% antibiotic–antimycotic solution
(Invitrogen).26,31,32 Our research protocol followed the
National Institutes of Health (NIH) guidelines for animal
care and was approved by the University of Pittsburgh’s
Institutional Animal Care and Use Committee and the
Children’s Hospital of Pittsburgh Animal Research Care
Committee.
Isolated rat MDSCs were passaged 15 times and expanded
to obtain enough cell number (at least 20 million cells per
mL).12,29 Fluorescent-activated cell sorting (FACS, FACS
Aria; BD Biosciences, San Jose, CA) revealed that cultured rat
MDSCs were approximately 60% positive to Sca-1 antigen
(BD Biosciences), and negative to CD34 (BD Biosciences),
CD45 (BD Biosciences), and c-kit (BD Biosciences) antigens
(Supplemental Fig. S1, available online at www.liebertonline
.com=ten; Table 1). Zuba-Surma et al. have shown that Sca-
1() skeletal muscle stem cells are ‘‘inherently predisposed to
undergo cardiac differentiation.15’’ Thus, we sorted Sca-1()
MDSCs that were expanded in standard two-dimensional
(2D) flasks for 48 h to reach a cell number of 3 million. These
Sca-1() MDSCs maintained no Sca-1 expression throughout
culture (Supplemental Fig. S2, available online at www
.liebertonline.com).
MDSC-3D collagen gel bioreactor
(MDSC-3DGB) construction
Expanded MDSCs on the 2D flask were trypsinized using
a 0.05% trypsin–EDTA solution (Invitrogen), and the cell
suspension was cultured on a 100-mm-diameter suspension
culture dish (Corning, Lowell, MA) for 24 h at 378C using a
gyrating shaker (50 rotations=min) to form 50- to 70-mm-
diameter MDSC aggregates (MDSC-aggregate, 330–350
cells=aggregate) under standard MDSC growth medium.
Acid-soluble rat tail collagen type-I solution (pH 3; Sigma,
St. Louis, MO) was neutralized with alkali buffer (0.2 M
NaHCO3, 0.2 M HEPES, and 0.1 M NaOH) on ice. Matrigel
(13% of total volume; BD Biosciences) was then added, and
the cell suspension and matrix solution mixed to reach a
final collagen type-I concentration of 0.67 mg=mL. Approxi-
mately 200mL of the cell=matrix mixture was poured into the
20-mm-long2-mm-wide cylindrical cast of a Flexcell Tissue
Train collagen type-I–coated silicone membrane culture plate
Table 1. Fluorescent-Activated Cell Sorting
Analysis of Unsorted Muscle-Derived Stem Cells
and Muscle-Derived Stem Cell-3DGB
% Positive
MDSCs
Sca-1 57.3 2.8 (n¼ 4)
CD34 0.1 0.0 (n¼ 4)
CD45 0.0 0.0 (n¼ 2)
c-kit 0.1 0.1 (n¼ 2)
MDSC-3DGB
cTn-T 18.6 2.5 (n¼ 3)
Data are mean standard error.
n, number of FACS sets. For MDSCs, 10 million cells=set and for
MDSC-3DGB, 6 MDSC-3DGBs=set.
FACS, fluorescent-activated cell sorting; MDSC, muscle-derived stem
cells; cTn-T, cardiac troponin-T; 3DGB, 3D collagen gel bioreactor.
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(FX4000TT; Flexcell International, Hillsborough, NC) and
incubated for 120 min (378C, 5% CO2)
32 to form a cylindrical
MDSC-3DGB. Each MDSC-3DGB was cultured in a 5% FBS
containing growth medium. We compared the efficiency of
CM induction from culture day 7 MDSC-3DGBs to (1) freshly
formed MDSC-aggregates after 24 h rotation culture in
standard culture medium; (2) two-dimensional MDSC cul-
ture (2D-MDSC) at culture day 7 on rat tail collagen type-I
(Sigma)–coated tissue culture plates (Corning) with 5% FBS
and Matrigel (17% of total volume, a concentration equiva-
lent to 3D culture, dissolved in cell suspension at the be-
ginning of culture; BD Biosciences); or (3) three-dimensional
MDSC culture (3D-MDSC) at culture day 7 in which the
MDSCs were embedded into collagen gel without MDSC-
aggregate formation. We also constructed engineered cardiac
tissue from gestational day 14 fetal cardiac cells (EFCT) or
neonatal day 1 cardiac tissue (ENCT) to investigate whether
MDSC-3DGB contractile properties mimic engineered car-
diac tissue from native immature cardiac cells. For EFCT
construction, pregnant mothers were anesthetized using 3%
isoflurane inhalation with 100% oxygen and hysterectomy
was performed. Immediately after hysterectomy, the mother
was euthanized by induced asystole under 5% isoflurane
anesthesia. The excised uteri were transferred to a sterilized
Petri dish filled with cold phosphate-buffered saline (PBS)
buffer and 1% antibiotic–antimycotic solution (Invitrogen),
the fetuses were excised by hysterotomy, and the fetal hearts
were harvested. Isolated cells were preplated for 1 h and then
cultured on a gyratory shaker (50 rotations=min) for 24 h to
reaggregate viable CMs for the cell suspension for 3D con-
struction. For ENCT construction, neonatal day 1 rat pups
were euthanized by cervical truncation under 5% inhaled
isoflurane with 100% oxygen, and the ventricular tissue was
excised and pooled. Great vessels and atrium were re-
moved from each heart, and ventricular tissue was collected
and pooled. Pooled ventricles were then enzymatically di-
gested by 2 mg=mL of collagenase type-II followed by 0.05%
trypsin–EDTA solution (Invitrogen). Isolated cells were
preplated for 1 h and then cultured on a gyratory shaker (50
rotations=min) for 24 h to reaggregate viable CMs for the cell
suspension for each construct. Engineered cardiac tissue
construction was the same as MDSC-3DGB, and the con-
structed EFCT or ENCT was cultured with 10% FBS con-
taining growth medium for 7 days.
Real-time–polymerase chain reaction
Total RNA was prepared using Trizol solution (Invitro-
gen) and treated with TURBO DNA-free kit (Ambion, Aus-
tin, TX). A cardiac a-actin primer was designed using
Primer-3 (forward 50–30 GCCCTGGATTTTGAGAATGA; re-
verse 50–30 CCTTTTGCATACGATCAGCA; product size of
289 bp). Other primers whose target genes were Nkx2.5,
GATA4, a- and b-cardiac myosin heavy chains (MHCs), and
connexin-43 (Cx-43) were obtained from Qiagen (Valencia,
CA) Quanti-Tect Primer Assay with the target fragment sizes
approximately 100 bp. One step real-time (RT) was per-
formed with a total volume of 1mg RNA in a total volume of
25 mL that used MuLy (Roches, Pleasanton, CA) with the
following program: 428C 15 min, 998C 5 min, 58C 5 min, one
cycle. cDNA (1 mL) was used for polymerase chain reaction
(PCR) that used the following program: 948C 2 min, 958C
50 s, 588C 30 s, 728C 1 min, 35 cycles 728C 7-min extension.
For normalization of RT-PCR results, b-actin was used as an
internal control. All PCR products were confirmed by Uni-
versity of Pittsburgh DNA Sequence Core Facilities, per-
formed by Eppendorf Mastercycles. All RT-PCR assays were
completed in triplicate (total n¼ 18 MDSC-3DGBs).
Sodium dodecyl sulfate–polyacrylamide gel
electrophoresis and immunoblotting
Whole cell lysates were prepared from native adult and
gestational day 20 fetal hearts (n¼ 6) and gastrocnemius
muscle tissue (n¼ 6), MDSC-3DGB tissue (n¼ 18), 3D-MDSC
(n¼ 18), and MDSC-aggregate (n¼ 6 culture plates) pooled
populations, and separated by sodium dodecyl sulfate–-
polyacrylamide gel electrophoresis (7.5% separating gel;
Bio-Rad Laboratories, Hercules, CA). Immunoblotting was
carried out using routine protocols. Each lane contained
20mg of total protein. Mouse monoclonal b-actin antibody
(Abcam, Cambridge, MA), mouse monoclonal cardiac
troponin-T (cTn-T; Abcam), mouse monoclonal anti-Cx-43
(Abcam), and mouse monoclonal cardiac troponin-I (cTn-I;
Abcam) were observed with IR-Dye 800 donkey anti-mouse
secondary antibody (Rockland Immunochemicals, Gilberts-
ville, PA). All proteins were observed using an infrared
Western blot imaging system (Odyssey; LI-COR Biosciences,
Lincoln, NE). Immunoblots were performed in triplicate and
quantified using densitometry and an expression ratio was
calculated (Odyssey, LI-COR Biosciences).
Confocal microscopy
Three-dimensional tissue constructs and fetal ventricular
samples were fixed with 4% paraformaldehyde=PBS for
15 min and embedded in the 13% polyacrylamide gel. One
hundred and fifty-micrometer-thick sections were made us-
ing a vibratory microtome (Vibratome-1000; Vibrotome.com,
St. Louis, MO).32 2D-MDSC samples were fixed with 4%
paraformaldehyde=PBS for 5 min. Sections or 2D-MDSC
samples were permeabilized with 0.1% Triton X-100 for 30 or
5 min, respectively, and stained for mouse monoclonal anti-
cTn-T (Abcam), cTn-I (Abcam), a-sarcomeric actinin (Sigma),
or Cx-43 (Abcam) primary antibodies and Alexa Fluor 488,
Alexa Fluor 647, or Alexa Fluor 594 secondary antibodies
(Invitrogen). We reconstructed 3D projection images from
stacks of z-axis optical scans using a standard laser confocal
microscopy system (FV1000; Olympus, Tokyo, Japan) and
Scion Image software (Scion, Frederick, MD).32 The com-
posite 3D projection images were further processed using
Adobe Photoshop software (Adobe, San Jose, CA).
Spontaneous beating activity
Culture day 7 MDSC-3DGBs (n¼ 8) were imaged at two
different regions=construct using a digital video microscopy
system and Scion Image Software with a CG-7 frame-grabber
board (Scion) to determine baseline spontaneous beat fre-
quency. MDSC-3DGBs were then treated with 2mM of the
nonselective b-adrenergic receptor agonist, isoproterenol
(ISP), or 1 mM of the nonselective sodium and calcium ion
channel inhibitor, cadmium chloride. Five minutes after
treatment, MDSC-3DGBs were imaged again, and were then
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incubated with fresh growth media for 15 min and re-imaged
to determine a posttreatment baseline.
Mechanical testing
The passive and active force of MDSC-3DGB (n¼ 7), 3D-
MDSC (n¼ 6), and EFCT (n¼ 7) constructs was measured as
previously described.32 In brief, each construct was trans-
ferred from the Flexcell culture dish to the perfusion chamber
of the muscle testing station containing a cold (258C) calcium-
free Ringer solution composed of (in mM): 135 NaCl, 4.0 KCl,
10 Trizma-HCl, 8.3 Trizma-base, and 11.0 glucose, and gassed
with 95% O2=5% CO2 (pH 7.4). One end of the construct was
attached to a force transducer (model 403A; Aurora Scienti-
fic, Aurora, Canada) and the other end to a length controller
mounted on a micromanipulator using 10-0 mono-
filament nylon sutures. The buffer within the perfusion
chamber (1.5 mL total chamber volume) was then replaced
with a warmed Ringer solution buffer (378C, containing 2 mM
Ca2þ) and perfused at a rate of 1 mL=min. The construct was
field-stimulated (1 Hz, 4 ms, 50–100 V, rectangular pulses)
using a stimulator (Harvard Apparatus, Holliston, MA). The
longitudinal length of the construct was increased in 5% in-
crements up to a 15% elongation from original length (L0.15).
The external diameters of the construct were recorded at each
stretch increment using a digital video microscopy system
(Model KPD-50; Hitachi, Tokyo, Japan and Scion Image
Software with a CG-7 frame-grabber board; Scion).
Intracellular free calcium ion transient recording
MDSC-3DGBs (n¼ 3) or ENCTs (n¼ 5) were loaded for
30 min at 258C with Fura 2-AM (Invitrogen) at a final con-
centration of 5 mM within a custom-built muscle chamber
equipped for the simultaneous measurement of force (force
transducer 403A, high-speed length controller model 22C
and 322C, digital control system Series 600A; Aurora Scien-
tific) and intracellular free calcium ([Ca2þ]i) recording using
fluorescent probes and IonOptix hardware and software
(IonOptix, Milton, MA). The muscle chamber was perfused
with 378C Ringer solution at a rate of 1 mL=min. MDSC-
3DGBs were field-stimulated (1 Hz, 5 ms, 50 V; Harvard Ap-
paratus), and Fura-2 fluorescence was recorded at a sampling
rate of 100 Hz by alternately illuminating the preparation with
light of 340- and 380-nm wavelength while measuring fluo-
rescence at 510 nm. Acquired data were stored for offline
analysis. To characterize [Ca2þ]i transients, the maximal ratio
(F340=F380) and minimal ratio (F340=F380) for 10 successive
transients were calculated and averaged. We also determined
[Ca2þ]i transients at L0.15, and pacing frequencies of 1 to 6 Hz.
Statistical analysis
Data are expressed as mean standard error. One-factor
analysis of variance was used to compare the protein anal-
ysis and spontaneous beat frequency among experimental
groups. Two-factor repeated analysis of variance was per-
formed to compare the active stress–length relations among
experimental groups. We performed a Tukey post hoc test to
determine individual differences between experimental
groups. Statistical significance was defined by a value of
p< 0.05. All calculations were performed using SigmaStat
(Systat Software, Point Richmond, CA).
Results
CM phenotypic cell differentiation within MDSC-3DGB
Before embedding MDSC-aggregates or MDSCs in 3D
culture, we assessed the cellular proliferation activity of
MDSC-aggregates. MDSC-aggregate formation significantly
decreased MDSC cellular proliferation (16.6 4.5% [n¼ 3
experimental sets, p< 0.05]) versus standard 2D culture
(36.1 2.8% [n¼ 3]) (Supplemental Fig. S3, available online
at www.liebertonline.com). When MDSC-aggregates were
cultured under standard 2D conditions, MDSC-aggregates
attached to the culture dish bottom within an hour and
MDSC-aggregates had completely disappeared and MDSCs
were randomly oriented similar to standard 2D-MDSC cul-
ture at 24 h. MDSC-aggregates expanded within each 3DGB
and the majority of cells aligned along the construct longitu-
dinal axis forming a muscle-like tissue (Fig. 1A), and the cells
were noted to spontaneously beat by culture day 5, which was
observed in all MDSC-3DGBs. The cells within 3D-MDSC
(without MDSC-aggregate formation) expanded along the
construct longitudinal axis by culture day 3, which was faster
than MDSC-aggregates placed in 3DGB. However, we noted a
lower incidence of spontaneous beating cells at culture day 7
within the 3D-MDSC constructs (6 of 36 constructs or 17%),
which was substantially lower than the spontaneous beating
rate of MDSC-3DGB constructs (48 of 48 constructs or 100%,
p< 0.05 by Fisher exact test). Synchronous tissue contraction
of MDSC-3DGB was observed by culture day 7 (Supple-
mental Movie, available online at www.liebertonline.com).
Histological assessment revealed that MDSC-3DGB con-
tained cells with cardiac-specific protein cTn-T organized in a
striated pattern (Fig. 1C), whereas the cTn-T–positive cells in
2D-MDSC were not organized in a clear striated pattern (Fig.
1D). MDSC-3DGB also expressed the cardiac-specific protein
cTn-I organized in a striated pattern similar to cTn-T (Fig. 1E,
F), whereas cTn-I was negative in 2D-MDSC. FACS analysis
based on cTn-T expression revealed that the fraction of cTn-T–
positive cells from culture day 7 MDSC-3DGB was
18.6 2.5% (from six MDSC-3DGBs in each FACS analysis,
three independent sets of pooled MDSC-3DGBs) (Supple-
mental Fig. S4, available online at www.liebertonline.com and
Table 1). Cx-43 was expressed in cTn-T–positive cells within
MDSC-3DGB, and the Cx-43 expression pattern of cTn-T–
positive cells was not typical to mature adult CMs, but was
similar to CMs of gestational day 20 native fetal left ventric-
ular papillary muscle (Fig. 2).
Cardiac-specific gene and protein expression
Cardiac-specific genes were expressed in culture day 7
MDSCs, regardless of the culture condition (Fig. 3), sug-
gesting that 7 days of culture can trigger cardiac gene ex-
pression of rat MDSCs. Western blots showed that both
MDSC-aggregates and 3D-MDSC and MDSC-3DGB groups
expressed cTn-T and Cx-43 proteins (Fig. 4A). Native tissue
protein expression shows that developmental stage alters
cardiac-specific protein expression in both heart and skeletal
muscle. Maturation causes cardiac-specific protein expres-
sion to increase in heart muscle and remain unchanged in
skeletal muscle. MDSC-3DGB had similar protein expression
to gestational day 20 fetal heart (Fig. 4A). Densitometry
analysis of each protein normalized to b-actin expression
378 CLAUSE ET AL.
demonstrated that 3D culture (MDSC-3DGB and 3D-MDSC
groups) was associated with higher cTn-T, Cx-43, and cTn-I
expression versus MDSC-aggregate culture ( p< 0.05).
Within 3D culture groups, we noted that both cTn-I and Cx-
43 expression levels were higher in the MDSC-3DGB group
than in the 3D-MDSC group ( p< 0.05) (Fig. 4B). Notably,
MDSC-3DGB had similar cTn-I and Cx-43 expression levels
as well as a cTn-T=cTn-I ratio (9.1 0.4 [n¼ 3]) to gestational
day 20 fetal heart (9.3 1.7 [n¼ 3]), which was significantly
different compared to adult ventricular tissue (0.8 0.1
[n¼ 4, p< 0.05]) cTn-T=cTn-I ratio as well as cTn-I and Cx-43
expression levels ( p< 0.05) (Fig. 4B). These data indicate that
while MDSCs express cardiac-specific genes at 7 days in
culture, regardless of culture method, the cardiac-specific
protein expression profiles differed with culture method;
specifically, MDSC-aggregate formation followed by 3DGB
culture synergistically increased induction of cells with an
immature CM phenotype.
Chronotropic effects of ISP and cadmium chloride
on MDSC-3DGB
Culture day 7 MDSC-3DGBs were treated with ISP or
cadmium chloride. Five minutes after treatment, ISP in-
creased MDSC-3DGB spontaneous beat frequency (5.62
0.54 Hz [n¼ 8, p< 0.05]) versus pretreatment (4.05 0.20 Hz
[n¼ 8]), whereas cadmium chloride suppressed spontaneous
beating activity (0.44 0.16 Hz [n¼ 8, p< 0.05]) compared to
pretreatment (4.27 0.44 Hz [n¼ 8]) (Fig. 5). No changes in
pretreatment baseline spontaneous beat frequency and
posttreatment baseline spontaneous beat frequency were
noted indicating reversible effects. These chronotropic re-
sponses do not occur in twitching mature skeletal muscle or
skeletal myotubes.16
Contractile properties of 3D MDSC culture
Upon field stimulation, both 3D-MDSC and MDSC-3DGB
generated contractile force. MDSC-3DGB generated con-
tractile force similar to engineered cardiac tissue from native
fetal cardiac cells (EFCT) (Fig. 6). MDSC-3DGB as well as
culture day 7 EFCT displayed a positive Frank-Starling re-
sponse to increased construct length, whereas 3D-MDSC did
not ( p< 0.05; Fig. 6B, C). MDSC-3DGB generated a greater
maximum active force (0.41 0.06 mN [n¼ 7, p< 0.05])
compared with 3D-MDSC (0.22 0.04 mN [n¼ 5]), which
was approximately one-third of EFCT (1.45 0.39 mN [n¼ 7,
p< 0.05]) (Fig. 6C).
[Ca2þ]i transients in MDSC-3DGB
We further investigated calcium handling by simulta-
neously recording contractile force and [Ca2þ]i transients
from culture day 7 MDSC-3DGB in which we observed
spontaneous tissue contraction. A rise in [Ca2þ]i preceded
FIG. 1. Histologic analysis of MDSC-3D collagen gel bioreactor (3DGB). (A) Phase contract image of culture day 7 MDSC-
3DGB. Scale bar indicates 500 mm. Red box indicates the area of the tissue where high-magnification images are taken. (B) a-
Sarcomeric actinin expression in MDSC-3DGB. Scale bar indicates 500mm. (C) Cardiac troponin-T (cTn-T) expressed in
oriented cells of MDSC-3DGB. Blue staining (DAPI) indicates nuclei. Scale bar indicates 50mm. The white double-head arrow
indicates MDSC-3DGB longitudinal axis. (D) cTn-T expression of MDSC-2D. Scale bar indicates 20mm. (E) cTn-T expression of
MDSC-3DGB was a typical striated muscle pattern at a higher magnification. Scale bar indicates 20 mm. (F) Cardiac troponin-I
(cTn-I) also expressed in a typical striated pattern (white arrowheads). Scale bar indicates 20 mm. 2D, two-dimensional; MDSC,
muscle-derived stem cell; DAPI, 40,6-diamidino-2-phenylindole. Color images available online at www.liebertonline.com=ten.
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force generation (Fig. 7A) and each [Ca2þ]i transient was
associated with a concurrent contraction. MDSC-3DGB dis-
played a negative force–frequency relationship between 1
and 6 Hz based on reduced [Ca2þ]i transients and active force
at increasing pacing rates and was associated with increased
diastolic ratio (suggesting increased diastolic [Ca2þ]i and
passive force) (Fig. 7B), similar to immature myocardi-
um.33,34 MDSC-3DGB force as well as [Ca2þ]i transient de-
veloped calcium (ratio¼ F340=F380) (0.48 0.16 [n¼ 3]) was
similar to ENCT (engineered cardiac tissue from cardiac cells
isolated from day 1 neonatal rats) (0.56 0.11 [n¼ 5]). These
data indicate that MDSC-3DGB display the [Ca2þ]i transient
features of immature CM with incomplete maturation of
excitation–contraction coupling.
Discussion
Previous studies have shown that stem cells isolated from
skeletal muscle specimens have the ability to differentiate
into CMs;8,14,16–19 however, the efficiency of CM differenti-
ation remains unclear and with limited functional charac-
terization. In the current study we found that (1) low-serum
growth medium–treated rat MDSCs expressed cardiac-
specific genes similar to native adult myocardium, consis-
tent with the findings of others in both human and mouse
skeletal muscle–derived cells, and (2) the combination of
MDSC-aggregate formation and 3DGB culture significantly
increased cardiac-specific protein expression, spontaneous
beating cell activity, and contractile properties. Our results
suggest that 3D microenvironmental cues provided by
MDSC-aggregate and 3DGB culture play an important role
in differentiation of cells with a functional CM phenotype
from MDSCs and the 3DGB system provides the necessary
environment to evaluate the contractile properties of these
differentiated CMs.
Various experiments have highlighted the importance of
the microenvironment on stem cell–derived CM induction,
differentiation, and survival.35,36 Tamaki et al. have recently
shown that skeletal muscle–derived multipotent Sk-34 cells
can give rise to CMs and that cell-to-cell relationships and
cellular milieu were important for this differentiation.18
However, these results were achieved with coculture with
embryonic CMs, and there was no functional characteriza-
tion of the SK-34–derived CMs in vitro. Thus, it is unclear
how these cells function in comparison to native CMs in
either a healthy or diseased heart. Rota et al. have shown that
bone marrow stem cells can engraft into the injured myo-
cardium and differentiate into functionally competent CMs
and vascular structures by establishing a microenvironment
necessary to adopt the cardiac phenotype.5 However, despite
these positive results there is still limited information on the
use of physical stimuli and unique microenvironments to
control CM induction from progenitor=stem cells, CM mat-
uration, and contractile function.
FIG. 2. Native fetal left ventricular papillary muscle at gestational day 20 stained for (A) a-sarcomeric actinin (green). (B)
Gap junction protein Cx-43 (red), and (C) merged. Culture day 7 MDSC-3DGB stained for (D) a-sarcomeric actinin (green).
(E) Gap junction protein Cx-43 (red), and (F) merged. Cx-43 expression of MDSC-3DGB was similar to gestational day 20 fetal
left ventricular papillary muscle Cx-43 expression. Blue staining (DAPI) indicates nuclei. Scale bar indicates 10mm. Cx-43,
connexin-43. Color images available online at www.liebertonline.com=ten.
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Three-dimensional growth of cells in aggregate spheres
has been shown to direct and facilitate cell–cell interactions
as well as to modify the differential expression of both
morphogenic and angiogenic pathways in CMs22 and he-
patocytes.37 Cell aggregate culture has been shown to en-
hance CM gene expression patterns,22 increase the synthesis
and release of ECM components,26 and accelerate CM dif-
ferentiation efficiency of embryonic stem cells25 and liver
stem cells.23 Similarly, Albrecht et al. found that chondrocyte
matrix biosynthesis was dependent on cell cluster size, rather
than overall cell density.38 Aggregate culture has also been
used to enhance survival and differentiation of various stem
cell types,25,39,40 versus static culture. These studies suggest
that aggregation imparts many of the necessary structural
cues required for maintaining differentiated phenotype, in-
cluding proper dimensionality, shape, cell–ECM, and cell–
cell interactions.
Cardiac cells within 3D cultured tissue display distinct
features that are more representative of native myocardium
than do cells within 2D culture.32,41 Bursac et al. investigated
the effect of 3D versus 2D culture on CM properties and
found that the 3D microenvironment plays a critical role in
maintenance of CM metabolism, sarcomere formation, cell-
to-cell connections, and electrophysiological properties.42
Three-dimensional growth of fibroblasts,1,4 endothelial cells,6
and mammary gland cells7 also exhibits cell morphology and
function similar to native tissue over 2D culture.43 In the
current study we showed that the 3D culture condition in-
creased differentiation of cells with a functional CM pheno-
type at both the gene and protein levels. Further, the
combination of MDSC-aggregate formation and 3DGB cul-
ture significantly increased expression of the cardiac-specific
proteins cTn-I and Cx-43 in comparison to the MDSC-
aggregate group, indicating that MDSC-aggregate formation
followed by 3DGB culture synergistically promoted differ-
entiation and maturation of cells with a functional CM
phenotype in vitro. Chronotropic effects of ISP and cad-
mium chloride treatment clearly showed that MDSC-3DGB
FIG. 3. Cardiac-specific mRNA expression. Lane 1, 2D-
MDSC evaluated after 7 days in culture; lane 2, MDSC-
aggregate evaluated after 24 h rotation culture; lane 3,
3D-MDSC (without MDSC-aggregate formation) evaluated 7
days after tissue construction; lane 4, MDSC-3DGB evaluated
7 days after tissue construction; lane 5, adult rat ventricular
tissue.
FIG. 4. Cardiac-specific protein quantification. (A) Repre-
sentative Western blot analysis of lane 1, MDSC-aggregate
evaluated after 24 h rotation culture; lane 2, 3D-MDSC
(without MDSC-aggregate formation) evaluated 7 days after
tissue formation; lane 3, MDSC-3DGB evaluated 7 days after
tissue formation; lane 4, gestational day 20 fetal rat ventric-
ular tissue; lane 5, twelve-week-old adult rat ventricular
tissue; lane 6, gestational day 20 fetal rat lower leg skeletal
muscle; lane 7, twelve-week-old adult rat gastrocnemius
muscle. (B) Densitometric data normalized to b-actin ex-
pression (average expression vs. b-actin, %). *p< 0.05 versus
MDSC-aggregate culture normalized expression. {p< 0.05
versus 3D-MDSC culture normalized expression. {p< 0.05
versus MDSC-3DGB culture normalized expression. Each
lane contains 20 mg of protein per sample, and experiments
were repeated in triplicate.
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contractile properties are mimicking cardiac tissue, not
twitching mature skeletal muscle or tissue derived from
myoblasts. MDSC-3DGB exhibited synchronous contraction
and cardiac [Ca2þ]i transients in response to electric field
stimulation similar to engineered cardiac tissue from native
CMs, suggesting that cells within MDSC-3DGB are a func-
tional syncytium. MDSC-3DGB exhibited a positive force–
length (Frank-Starling) and a negative force–frequency
relationship consistent with incomplete maturation of CM
calcium cycling32,44 that was similar to engineered cardiac
tissue from native fetal CMs. These results suggested that the
combination of MDSC-aggregate formation and 3DGB tissue
culture was required for differentiation of cells with a func-
tioning CM phenotype from MDSCs.
Studies in cellular cardiomyoplasty showed that the mi-
croenvironment of the injured myocardium includes the re-
lease of matrix factors and cytokines that are clearly not
conducive to supporting CM induction and=or survival from
implanted stem cells.45,46 This may inhibit proper CM re-
generation and=or lead to the potential for inappropriate
differentiation in the absence of the proper cell-specific milieu.
Therefore, our MDSC-3DGB provides a novel method for
studying and optimizing in vitro conditioning of the micro-
mechanical environment with direct assessment of contractile
properties, and its role in stem cell commitment to functioning
CMs from MDSCs in vitro. Although the results of our current
study clearly indicate that combined MDSC-aggregate for-
mation and 3DGB culture drives induction of cells with a
functioning cardiac phenotype from MDSCs and that the
contractile properties mimic those of engineered tissue from
native fetal cells, the underlying mechanisms as to how the 3D
microenvironment regulates this induction from MDSCs re-
mains unclear and necessitates further studies.
There are several limitations that need to be mentioned. A
major limitation to the current study is that we cannot de-
finitively determine the state of the CM-like cells within
MDSC-3DGB. This is most likely due to the coexistance of
many cardiac and skeletal muscle–specific proteins (MHCs,
troponins, etc.) as well as excitation–contraction coupling
mechanisms that occur not only in cultured cells, especially
those that are considered to be immature, but also within the
developing tissue. Cognard et al. have shown that cardiac and
skeletal excitation–contraction coupling mechanisms coexist
in the developing skeletal muscle with the cardiac type
dominant in the early phases of myogenesis and the skeletal
dominating in more mature muscle.47 Rose et al. have re-
ported bone marrow–derived mesenchymal stromal cells that
acquire expression of CM genes in in vitro coculture with
native CMs but that did not generate action potentials or
display ionic currents typical of CMs, and thus remain
functionally non-CM.48 Therefore, further studies are neces-
sary to determine whether CM phenotypic cells within
MDSC-3DGB develop further and mature similarly to the
native developing immature myocardium, and whether
the 3DGB culture in its present form is able to do this. In the
present study, we showed that cTn-T–positive cells consist of
approximately 20% of the entire number of MDSCs within the
MDSC-3DGB, a population which may contain both undif-
ferentiated MDSCs and MDSCs differentiated into other
types of cells. Thus, it is necessary to develop a method to
enrich CM phenotype cells from the MDSC-3DGB. It is likely
that more contractile apparatuses within each differentiated
FIG. 5. Effects of ISP and CdCl2 treatment on spontaneous
beating activity of MDSC-3DGB. Culture day 7 MDSC-
3DGBs treated with 2mM ISP for 5 min increased spontane-
ous beat frequency. MDSC-3DGBs treated with 1 mM
CdCl2 for 5 min decreased spontaneous beating. *p< 0.05
versus pretreatment. ISP, isoproterenol; CdCl2, cadmium
chloride.
FIG. 6. Biomechanical testing of MDSC-3DGB. (A) MDSC-
3DGB mounted on a mechanical testing station (white ar-
row). Scribed x-axis minor scale divisions represent 1 mm.
(B) Representative contractile force tracing of MDSC-3DGB
at increasing resting lengths. (C) Active force–strain relations
of culture day 7 MDSC-3DGB, culture day 7 3D-MDSC, and
EFCT at strain deviations of 0 to 0.15. {p< 0.05 versus
MDSC-3DGB. Active force increased in response to increased
strain (positive Frank-Starling response, *p< 0.05, analysis of
variance). Color images available online at www.liebertonline
.com=ten.
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CM as well as more CMs within MDSC-3DGB (*20% com-
pared to *60–70% within EFCT) and a better organization
and communication within the tissue would serve to increase
the contractile properties to be similar to the EFCT or native
tissue; however, further studies are necessary. Similarly, it is
also necessary to observe the CM phenotypic cells within
MDSC-3DGB over longer culture periods. It is possible that
the CM phenotypic cells will (1) acquire a more mature CM
phenotype, (2) remain an immature CM population, or (3)
return to an undifferentiated state. It remains unknown
whether CM differentiation and maturation from MDSCs
require other types of cells in vitro. Previous studies have
shown that preconditioned MDSCs transplanted into injured
myocardium survive and differentiate into a more matured
CM phenotype based on histological assessment,16–18 while
in the current study, differentiated cells exhibited a more
immature CM phenotype. The factors that drive differenti-
ated CM phenotypic cells toward a more mature CM phe-
notype remain unknown.
Conclusion
In summary, our results suggest that 3D environmental
cues provided by MDSC-aggregate formation and 3DGB
culture are complementary and sufficient to trigger differ-
entiation of cells with an immature functioning CM pheno-
type from rat skeletal MDSCs in vitro and that this 3DGB
culture can be used as a method to directly assess the con-
tractile properties of differentiated CMs from MDSCs in vitro.
This novel induction approach may be useful in generating
scalable, functioning, donor CMs for cardiac repair and
regeneration.
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FIG. 7. Simultaneous contractile
force and [Ca2þ]i transient measure-
ment of MDSC-3DGB. (A) Re-
presentative single beat force (red)
fluorescence at 340 nm (green) and at
380 nm (blue), and the relative fluo-
rescence (ratio [R¼ F340=F380]) (black)
tracing of culture day 7 MDSC-3DGB
electrically stimulated at 1 Hz at 50 V
and 4 ms duration. A rise in [Ca2þ]i
preceded force generation and each
[Ca2þ]i transient was associated with a
concurrent contraction. (B) Culture
day 7 MDSC-3DGB electrically stimu-
lated at rates of 1 to 6 Hz at 50 V and
4 ms duration. MDSC-3DGB showed
increased diastolic [Ca2þ]i and reduced
systolic [Ca2þ]i transient ratios (black)
associated with increased diastolic and
decreased active force (red) at in-
creasing pacing rates, similar to im-
mature myocardium. [Ca2þ]i,
intracellular free calcium ion. Color
images available online at www
.liebertonline.com=ten.
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